{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "anthracyclines",
      "cancer",
      "cardio-oncology",
      "cardiotoxicity",
      "chemotherapy",
      "heart disease",
      "prevention",
      "treatment"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "31988687",
  "DateCompleted": {
    "Year": "2020",
    "Month": "05",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "05",
    "Day": "05"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.14797/mdcj-15-4-267"
    ],
    "Journal": {
      "ISSN": "1947-6108",
      "JournalIssue": {
        "Volume": "15",
        "Issue": "4",
        "PubDate": {
          "Year": "2019",
          "Season": "Oct-Dec"
        }
      },
      "Title": "Methodist DeBakey cardiovascular journal",
      "ISOAbbreviation": "Methodist Debakey Cardiovasc J"
    },
    "ArticleTitle": "Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity.",
    "Pagination": {
      "StartPage": "267",
      "EndPage": "273",
      "MedlinePgn": "267-273"
    },
    "Abstract": {
      "AbstractText": [
        "Recent decades have seen an increase in survival rates for cancer patients, partially explained by earlier diagnoses and new chemotherapeutic agents. However, chemotherapy may be associated with adverse cardiovascular events, including hypertension and pulmonary hypertension, supraventricular and ventricular arrhythmias, cardiomyopathy, and other forms of cardiovascular disease. For patients, the benefits of chemotherapy may be partially obfuscated by deleterious effects on the cardiovascular system, resulting in a significant increase in morbidity and mortality. In this article, we review strategies for prevention and treatment of chemotherapy-related cardiotoxicity."
      ],
      "CopyrightInformation": "\u00a9 2019 Houston Methodist Hospital Houston, Texas."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "HOSPITAL DAS CLINICAS DA FACULDADE DE MEDICINA DA UNIVERSIDADE DE SAO PAULO, SAO PAULO, BRAZIL."
          }
        ],
        "LastName": "Avila",
        "ForeName": "Monica Samuel",
        "Initials": "MS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "HOSPITAL DAS CLINICAS DA FACULDADE DE MEDICINA DA UNIVERSIDADE DE SAO PAULO, SAO PAULO, BRAZIL."
          }
        ],
        "LastName": "Siqueira",
        "ForeName": "Suellen Rodrigues Rangel",
        "Initials": "SRR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "HOSPITAL DAS CLINICAS DA FACULDADE DE MEDICINA DA UNIVERSIDADE DE SAO PAULO, SAO PAULO, BRAZIL."
          }
        ],
        "LastName": "Ferreira",
        "ForeName": "Silvia Moreira Ayub",
        "Initials": "SMA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "HOSPITAL DAS CLINICAS DA FACULDADE DE MEDICINA DA UNIVERSIDADE DE SAO PAULO, SAO PAULO, BRAZIL."
          }
        ],
        "LastName": "Bocchi",
        "ForeName": "Edimar Alcides",
        "Initials": "EA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Methodist Debakey Cardiovasc J",
    "NlmUniqueID": "101508600",
    "ISSNLinking": "1947-6108"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [
        "chemically induced",
        "diagnosis",
        "prevention & control",
        "therapy"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Assessment"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    }
  ],
  "CoiStatement": "Conflict of Interest Disclosure: The authors have completed and submitted the Methodist DeBakey Cardiovascular Journal Conflict of Interest Statement and none were reported."
}